Simplex Trading
OCUL icon

Simplex Trading’s Ocular Therapeutix OCUL Stock Holding History

Simplex Trading’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$902K Sell
106,500
-44,100
-29% -$420K ﹤0.01% 2617
2025
Q4 		$1.83M Buy
150,600
+106,100
+238% +$1.29M ﹤0.01% 2052
2025
Q3 		$520K Sell
44,500
-18,000
-29% -$215K ﹤0.01% 3775
2025
Q2 		$580K Sell
62,500
-41,900
-40% -$328K ﹤0.01% 3341
2025
Q1 		$765K Buy
104,400
+13,900
+15% +$107K ﹤0.01% 2961
2024
Q4 		$772K Buy
90,500
+50,000
+123% +$488K ﹤0.01% 3110
2024
Q3 		$352K Sell
40,500
-31,300
-44% -$258K ﹤0.01% 3968
2024
Q2 		$491K Sell
71,800
-115,800
-62% -$715K ﹤0.01% 3689
2024
Q1 		$1.71M Buy
187,600
+120,900
+181% +$858K ﹤0.01% 2568
2023
Q4 		$297K Buy
66,700
+64,800
+3,411% +$192K ﹤0.01% 4236
2023
Q3 		$5K Sell
1,900
-20,600
-92% -$84.3K ﹤0.01% 7674
2023
Q2 		$116K Sell
22,500
-11,600
-34% -$69K ﹤0.01% 4892
2023
Q1 		$179K Buy
34,100
+12,700
+59% +$60.3K ﹤0.01% 4463
2022
Q4 		$60K Sell
21,400
-200
-0.9% -$662 ﹤0.01% 5648
2022
Q3 		$89K Buy
21,600
+20,900
+2,986% +$105K ﹤0.01% 5680
2022
Q2 		$2K Sell
700
-2,600
-79% -$9.82K ﹤0.01% 9395
2022
Q1 		$16K Sell
3,300
-13,000
-80% -$72.1K ﹤0.01% 8471
2021
Q4 		$113K Sell
16,300
-30,200
-65% -$235K ﹤0.01% 6058
2021
Q3 		$666K Buy
46,500
+100
+0.2% +$1.12K ﹤0.01% 3676
2021
Q2 		$657K Buy
+46,400
New +$705K ﹤0.01% 3743
2021
Q1 		– Sell
-80
Closed -$165K – 9670
2020
Q4 		$165K Sell
80
-153
-66% -$2.27K ﹤0.01% 4857
2020
Q3 		$177K Buy
233
+210
+913% +$1.74K ﹤0.01% 4269
2020
Q2 		$19K Buy
23
+11
+92% +$73 ﹤0.01% 6262
2020
Q1 		$5K Buy
+12
New +$59 ﹤0.01% 6855
2019
Q4 		– Sell
-85
Closed -$25K – 7769
2019
Q3 		$25K Hold
85
– – ﹤0.01% 5649
2019
Q2 		$37K Buy
85
+54
+174% +$200 ﹤0.01% 5112
2019
Q1 		$12K Sell
31
-5
-14% -$20 ﹤0.01% 6053
2018
Q4 		$14K Buy
36
+21
+140% +$116 ﹤0.01% 5620
2018
Q3 		$10K Buy
+15
New +$94 ﹤0.01% 6418
2018
Q2 		– Sell
-50
Closed -$1K – 7739
2018
Q1 		$1K Buy
50
+30
+150% +$169 ﹤0.01% 5719
2017
Q4 		$1K Sell
20
-31
-61% -$158 ﹤0.01% 5581
2017
Q3 		$1K Buy
51
+12
+31% +$77 ﹤0.01% 5517
2017
Q2 		$8K Sell
39
-68
-64% -$658 ﹤0.01% 4184
2017
Q1 		$8K Sell
107
-41
-28% -$341 ﹤0.01% 4181
2016
Q4 		$7K Sell
148
-13
-8% -$101 ﹤0.01% 4070
2016
Q3 		$81K Sell
161
-29
-15% -$177 0.01% 1710
2016
Q2 		$54K Buy
190
+147
+342% +$1.46K ﹤0.01% 1976
2016
Q1 		$9K Buy
43
+9
+26% +$68 ﹤0.01% 3581
2015
Q4 		$7K Buy
34
+10
+42% +$108 ﹤0.01% 3629
2015
Q3 		$7K Buy
+24
New +$482 ﹤0.01% 3751

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Simplex Trading's OCUL Position: Q1 2026 in Review

Simplex Trading reduced its Ocular Therapeutix (OCUL) stake by 66% in Q1 2026, selling an estimated $101K and leaving 5,555 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #5944.

Simplex Trading first reported a position in OCUL in Q3 2015 and has held it in 34 quarters since. The position peaked at $829K in Q4 2020. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

  • Simplex Trading held 5,555 shares of Ocular Therapeutix worth $47K as of Q1 2026.
  • Simplex Trading sold 10,647 Ocular Therapeutix shares in Q1 2026, an estimated $101K.
  • Ocular Therapeutix made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5944 holding.
  • Simplex Trading first reported a position in Ocular Therapeutix in Q3 2015 and has held it in 34 quarters since.
  • Simplex Trading's Ocular Therapeutix position peaked at $829K in Q4 2020.
  • 269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.